Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: Relevance to immunity, autoimmunity, and cancer

Archivum Immunologiae et Therapiae Experimentalis

Volumn 56, Issue 5, 2008, Pages 311-323

  Ramanathan, Sheela ^b   Gagnon, Julien ^b   Ilangumaran, Subburaj ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b NONE

Author keywords

Autoimmunity; Cancer; CD8+ T lymphocytes; Cytokines; Immune response

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 7; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL SURVIVAL; CELL THERAPY; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTOPENIA; NEOPLASM; NONHUMAN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; HUMANS; IMMUNITY; LYMPHOCYTE ACTIVATION; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

EID: 53849145996     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-008-0033-2     Document Type: Review

References (173)

1. Alves N. L., Arosa F. A. and van Lier R. A. (2005): IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells. J. Immunol., 175, 755-762.
2. Alves N. L., Hooibrink B., Arosa F. A. and van Lier R. A. (2003): IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood, 102, 2541-2546.
3. Badovinac V. P., Porter B. B. and Harty J. T. (2002): Programmed contraction of CD8(+) T cells after infection. Nat. Immunol., 3, 619-626.
4. Banchereau J. and Palucka A. K. (2005): Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol., 5, 296-306.
5. Banchereau J. and Steinman R. M. (1998): Dendritic cells and the control of immunity. Nature, 392, 245-252.
6. Becker T. C., Wherry E. J., Boone D., Murali-Krishna K., Antia R., Ma A. and Ahmed R. (2002): Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med., 195, 1541-1548.
7. Blattman J. N., Grayson J. M., Wherry E. J., Kaech S. M., Smith K. A. and Ahmed R. (2003): Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med., 9, 540-547.
8. Boyman O., Purton J. F., Surh C. D. and Sprent J. (2007): Cytokines and T-cell homeostasis. Curr. Opin. Immunol., 19, 320-326.
9. Brehm M. A., Pinto A. K., Daniels K. A., Schneck J. P., Welsh R. M. and Selin L. K. (2002): T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol., 3, 627-634.
10. Burchill M. A., Goetz C. A., Prlic M., O'Neil J. J., Harmon I. R., Bensinger S. J., Turka L. A., Brennan P., Jameson S. C. and Farrar M. A. (2003): Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J. Immunol., 171, 5853-5864.
11. Calzascia T., Pellegrini M., Lin A., Garza K. M., Elford A. R., Shahinian A., Ohashi P. S. and Mak T. W. (2008): CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc. Natl. Acad. Sci. USA, 105, 2999-3004.
12. Casey K. A. and Mescher M. F. (2007): IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype. J. Immunol., 178, 7640-7648.
13. Chianese-Bullock K. A., Woodson E. M., Tao H., Boerner S. A., Smolkin M., Grosh W. W., Neese P. Y., Marrill P., Petroni G. R. and Slingluff C. L. Jr. (2005): Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2. J. Immunother., 28, 412-419.
14. Cho B. K., Rao V. P., Ge Q., Eisen H. N. and Chen J. (2000): Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med., 192, 549-556.
15. Cho B. K., Wang C., Sugawa S., Eisen H. N. and Chen J. (1999): Functional differences between memory and naive CD8 T cells. Proc. Natl. Acad. Sci. USA, 96, 2976-2981.
16. Cho J. H., Boyman O., Kim H. O., Hahm B., Rubinstein M. P., Ramsey C., Kim D. M., Surh C. D. and Sprent J. (2007): An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2. J. Exp. Med., 204, 1787-1801.
17. Coquet J. M., Kyparissoudis K., Pellicci D. G., Besra G., Berzins S. P., Smyth M. J. and Godfrey D. I. (2007): IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol., 178, 2827-2834.
18. Curtsinger J. M., Johnson C. M. and Mescher M. F. (2003): CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol., 171, 5165-5171.
19. Curtsinger J. M., Valenzuela J. O., Agarwal P., Lins D. and Mescher M. F. (2005): Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol., 174, 4465-4469.
20. D'Souza W. N. and Lefrancois L. (2003): IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J. Immunol., 171, 5727-5735.
21. Dai Z., Arakelov A., Wagener M., Konieczny B. T. and Lakkis F. G. (1999): The role of the common cytokine receptor gamma-chain in regulating IL-2- dependent, activation-induced CD8+ T cell death. J. Immunol., 163, 3131-3137.
22. Davey G. M., Starr R., Cornish A. L., Burghardt J. T., Alexander W. S., Carbone F. R., Surh C. D. and Heath W. R. (2005): SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential. J. Exp. Med., 202, 1099-1108.
23. Davila E., Velez M. G., Heppelmann C. J. and Celis E. (2002): Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment. Blood, 100, 2537-2545.
24. Delon J., Bercovici N., Raposo G., Liblau R. and Trautmann A. (1998): Antigen-dependent and -independent Ca2+ responses triggered in T cells by dendritic cells compared with B cells. J. Exp. Med., 188, 1473-1484.
25. den Haan J. M. and Bevan M. J. (2001): Antigen presentation to CD8+ T cells: cross-priming in infectious diseases. Curr. Opin. Immunol., 13, 437-441.
26. Dubois S., Mariner J., Waldmann T. A. and Tagaya Y. (2002): IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity, 17, 537-547.
27. Dudley M. E., Wunderlich J. R., Robbins P. F., Yang J. c., Hwu P., Schwartzentruber D. J., Topalian S. L., Sherry R., Restifo N. P., Hubicki A. M., Robinson M. R., Raffeld M., Duray P., Seipp C. A., Rogers-Freezer L., Morton K. E., Mavroukakis S. A., White D. E. and Rosenberg S. A. (2002): Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science, 298, 850-854.
28. Dudley M. E., Wunderlich J. R., Yang J. C., Sherry R. M., Topalian S. L., Restifo N. P., Royal R. E., Kammula U., White D. E., Mavroukakis S. A., Rogers L. J., Gracia G. J., Jones S. A., Mangiameli D. P., Pelletier M. M., Gea-Banacloche J., Robinson M. R., Berman D. M., Filie A. C., Abati A. and Rosenberg S. A. (2005): Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol., 23, 2346-2357.
29. Ehl S., Hombach J., Aichele P., Hengartner H. and Zinkernagel R. M. (1997): Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J. Exp. Med., 185, 1241-1251.
30. Ernst B., Lee D. S., Chang J. M., Sprent J. and Surh C. D. (1999): The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity, 11, 173-181.
31. Fehniger T. A., Suzuki K., Pannappan A., VanDeusen J. B., Cooper M. A., Florea S. M., Freud A. G., Robinson M. L., Durbin J. and Caligiuri M. A.. (2001): Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J. Exp. Med., 193, 219-231.
32. Figdor C. G., de Vries I. J., Lesterhuis W. J. and Melief C. J. (2004): Dendritic cell immunotherapy: mapping the way. Nat. Med., 10, 475-480.
33. Finke J., Ferrone S., Frey A., Mufson A. and Ochoa A. (1999): Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol. Today, 20, 158-160.
34. Freitas A. A. and Rocha B. (2000): Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol., 18, 83-111.
35. Gagnon J., Ramanathan S., Leblanc C., Cloutier A., McDonald P. and Ilangumaran S. (2008): IL-6, in synergy with IL-7 or IL-15, stimulates TCR-independent proliferation and functional differentiation of CD8+ T lymphocytes. J. Immunol., 180, 7958-7968.
36. Gagnon J., Ramanathan S., Leblanc C. and Ilangumaran S. (2007): Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8(+) T lymphocytes. Cell Signal, 19, 806-816.
37. Galkina E., Florey O., Zarbock A., Smith B. R., Preece G., Lawrence M. B., Haskard D. O. and Ager A. (2007): T lymphocyte rolling and recruitment into peripheral lymph nodes is regulated by a saturable density of L-selectin (CD62L). Eur. J. Immunol., 37, 1243-1253.
38. Galkina E., Tanousis K., Preece G., Tolaini M., Kioussis D., Florey O., Haskard D. O., Tedder T. F. and Ager A.. (2003): L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes. J. Exp. Med., 198, 1323-1335.
39. Gallegos A. M. and Bevan M. J. (2004): Driven to autoimmunity: the nod mouse. Cell, 117, 149-151.
40. Gattinoni L., Klebanoff C. A., Palmer D. C., Wrzesinski C., Kerstann K., Yu Z., Finkelstein S. E., Theoret M. R., Rosenberg S. A. and Restifo N. P. (2005): Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J. Clin. Invest., 115, 1616-1626.
41. Ge Q., Palliser D., Eisen H. N. and Chen J. (2002): Homeostatic T cell proliferation in a T cell-dendritic cell coculture system. Proc. Natl. Acad. Sci. USA, 99, 2983-2988.
42. Geginat J., Lanzavecchia A. and Sallusto F. (2003): Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood, 101, 4260-4266.
43. Geginat J., Sallusto F. and Lanzavecchia A. (2001): Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J. Exp. Med., 194, 1711-1719.
44. Gleeson P. A., Toh B. H. and van Driel I. R. (1996): Organ-specific autoimmunity induced by lymphopenia. Immunol. Rev., 149, 97-125.
45. Goldrath A. W., Bogatzki L. Y. and Bevan M. J. (2000): Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med., 192, 557-564.
46. Goldrath A. W., Sivakumar P. V., Glaccum M., Kennedy M. K., Bevan M. J., Benoist C., Mathis D. and Butz E. A. (2002): Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J. Exp. Med., 195, 1515-1522.
47. Haring J. S., Badovinac V. P. and Harty J. T. (2006): Inflaming the CD8+ T cell response. Immunity, 25, 19-29.
48. Harty J. T., Tvinnereim A. R. and White D. W. (2000): CD8+ T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol., 18, 275-308.
49. Heinrich P. C., Behrmann I., Haan S., Hermanns H. M., Muller-Newen G. and Schaper F. (2003): Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J., 374, 1-20.
50. Hildeman D. A., Zhu Y., Mitchell T. C., Kappler J. and Marrack P. (2002): Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol., 14, 354-359.
51. Hinrichs C. S., Spolski R., Paulos C. M., Gattinoni L., Kerstann K. W., Palmer D. C., Klebanoff C. A., Rosenberg S. A., Leonard W. J. and Restifo N. P. (2008): IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood, 111, 5326-5333 .
52. Hirano F., Kaneko K., Tamura H., Dong H., Wang S., Ichikawa M., Rietz C., Flies D. B., Lau J. S., Zhu G., Tamada K. and Chen L. (2005): Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res., 65, 1089-1096.
53. Hofmeister R., Khaled A. R., Benbernou N., Rajnavolgyi E., Muegge K. and Durum S. K. (1999): Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev., 10, 41-60.
54. Hurst S. M., Wilkinson T. S., McLoughlin R. M., Jones S., Horiuchi S., Yamamoto N., Rose-John S., Fuller G. M., Topley N. and Jones S. A. (2001): IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity, 14, 705-714.
55. Ihle J. N. (1995): Cytokine receptor signalling. Nature, 377, 591-594.
56. Ilangumaran S., Ramanathan S., La Rose J., Poussier P. and Rottapel R. (2003): Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes. J. Immunol., 171, 2435-2445.
57. Ilangumaran S., Ramanathan S. and Rottapel R. (2004): Regulation of the immune system by SOCS family adaptor proteins. Semin. Immunol., 16, 351-365.
58. Ishihara K. and Hirano T. (2002): IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev., 13, 357-368.
59. Jameson S. C. (2002): Maintaining the norm: T-cell homeostasis. Nat. Rev. Immunol., 2, 547-556.
60. Jiang Q., Li W. Q., Aiello F. B., Mazzucchelli R., Asefa B., Khaled A. R. and Durum S. K. (2005): Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev., 16, 513-533.
61. Jones S. A. (2005): Directing transition from innate to acquired immunity: defining a role for IL-6. J. Immunol., 175, 3463-3468.
62. Jun H. S. and Yoon J. W. (2003): A new look at viruses in type 1 diabetes. Diabetes Metab. Res. Rev., 19, 8-31.
63. Kamimura D. and Bevan M. J. (2007): Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. J. Exp. Med., 204, 1803-1812.
64. Kaplanski G., Marin V., Montero-Julian F., Mantovani A. and Farnarier C. (2003): IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol., 24, 25-29.
65. Kennedy M. K., Glaccum M., Brown S. N., Butz E. A., Winey J. L., Embers M., Matsuki N., Charrier K., Sedger L., Willis C. R., Brasel K., Morrissey P. J., Stocking K., Schuh J. C., Joyce S. and Peschon J. J. (2000): Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med., 191, 771-780.
66. Kieper W. C., Tan J. T., Bondi-Boyd B., Gapin L., Sprent J., Ceredig R. and Surh C. D. (2002): Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8(+) T cells. J. Exp. Med., 195, 1533-1539.
67. King C., Ilic A., Koelsch K. and Sarvetnick N. (2004): Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell, 117, 265-277.
68. Kishida T., Asada H., Itokawa Y., Cui F. D., Shin-Ya M., Gojo S., Yasutomi K., Ueda Y., Yanagusgu H., Imanishi J. and Mazda O. (2003): Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Mol. Ther., 8, 552-558.
69. Kolumam G. A., Thomas S., Thompson L. J., Sprent J. and Murali-Krishna K. (2005): Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med., 202, 637-650.
70. Kondo T., Cortese I., Markovic-Plese S., Wandinger K. P., Carter C., Brown M., Leitman S. and Martin R. (2001): Dendritic cells signal T cells in the absence of exogenous antigen. Nat. Immunol., 2, 932-938.
71. Kovanen P. E. and Leonard W. J. (2004): Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev., 202, 67-83.
72. Kundig T. M., Shahinian A., Kawai K., Mittrucker H. W., Sebzda E., Bachmann M. F., Mak T. W. and Ohashi P. S. (1996): Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity, 5, 41-52.
73. La Gruta N. L., Driel I. R. and Gleeson P. A. (2000): Peripheral T cell expansion in lymphopenic mice results in a restricted T cell repertoire. Eur. J. Immunol., 30, 3380-3386.
74. Lake R. A. and Robinson B. W. (2005): Immunotherapy and chemotherapy-a practical partnership. Nat. Rev. Cancer, 5, 397-405.
75. Lenardo M. J. (1991): Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature, 353, 858-861.
76. Lin J. X., Migone T. S., Tsang M., Friedmann M., Weatherbee J. A., Zhou L., Yamauchi A., Bloom E. T., Mietz J., John S. et al. (1995): The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity, 2, 331-339.
77. Lodolce J. P., Boone D. L., Chai S., Swain R. E., Dassopoulos T., Trettin S. and Ma A. (1998): IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity, 9, 669-676.
78. Lundmark F., Duvefelt K., Iacobaeus E., Kockum I., Walkstrom E., Khademi M., Oturai A., Ryder L. P., Saarela J., Harbo H. F., Celius E. G., Salter H., Olsson T. and Hillert J. (2007): Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet., 39, 1108-1113.
79. Ma A., Boone D. L. and Lodolce J. P. (2000): The pleiotropic functions of interleukin 15: not so interleukin 2-like after all. J. Exp. Med., 191, 753-756.
80. Maker A. V., Phan G. Q., Attia P., Yang J. C., Sherry R. M., Topalian S. L., Kammula U. S., Royal R. E., Haworth L. R., Levy C., Kleiner D., Mvroukakis S. A., Yellin M. and Rosenberg S. A. (2005): Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann. Surg. Oncol., 12, 1005-1016.
81. Manjunath N., Shankar P., Wan J., Weininger W., Crowley M. A., Hieshima K., Springer T. A., Fan X., Shen H., Lieberman J. and von Andrian U. H. (2001): Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest., 108, 871-878.
82. Marks-Konczalik J., Dubois S., Losi J. M., Sabzevari H., Yamada N., Feigenbaum L., Waldmann T. A. and Tagaya Y. (2000): IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc. Natl. Acad. Sci. USA, 97, 11445-11450.
83. Marrack, P., Bender J., Hildeman D., Jordan M., Mitchell T., Murakami M., Sakamoto A., Schaefer B. C., Swanson B. and Kappler J. (2000): Homeostasis of alpha beta TCR+ T cells. Nat. Immunol., 1, 107-111.
84. Marrack P. and Kappler J. (2004): Control of T cell viability. Annu .Rev. Immunol., 22, 765-787.
85. Marrack P., Kappler J. and Mitchell T. (1999): Type I interferons keep activated T cells alive. J. Exp. Med., 189, 521-530.
86. Matikainen S., Sareneva T., Ronni T., Lehtonen A., Koskinen P. J. and Julkunen I. (1999): Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood, 93, 1980-1991.
87. Mattei F., Schiavoni G., Belardelli F. and Tough D. F. (2001): IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol., 167, 1179-1187.
88. McAdam A. J., Schweitzer A. N. and Sharpe A. H. (1998): The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol. Rev., 165, 231-247.
89. McInnes I. B. and Liew F. Y. (1998): Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunol. Today, 19, 75-79.
90. McLoughlin R. M., Jenkins B. J., Grail D., Williams A. S., Fielding C. A., Parker C. R., Ernst M., Topley N. and Jones S. A. (2005): IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc. Natl. Acad. Sci. USA, 102, 9589-9594.
91. Mescher M. F., Curtsinger J. M., Agarwal P., Casey K. A., Gerner M., Hammerbeck C. D., Popescu F. and Xiao Z. (2006): Signals required for programming effector and memory development by CD8+ T cells. Immunol. Rev., 211, 81-92.
92. Mitchell T., Kappler J. and Marrack P. (1999): Bystander virus infection prolongs activated T cell survival. J. Immunol., 162, 4527-4535.
93. Mizoguchi H., O'Shea J. J., Longo D. L., Loeffler C. M., McVicar D. W. and Ochoa A. C. (1992): Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science, 258, 1795-1798.
94. Murali-Krishna K. and Ahmed R. (2000): Cutting edge: naive T cells masquerading as memory cells. J. Immunol., 165, 1733-1737.
95. Murali-Krishna K., Altman J. D., Suresh M., Sourdive D. J., Zajac A. J., Miller J. D., Slansky J. and Ahmed R. (1998): Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity, 8, 177-187.
96. Murali-Krishna K., Lau L. L., Sambhara S., Lemonnier F., Altman J. and Ahmed R. (1999): Persistence of memory CD8 T cells in MHC class I-deficient mice. Science, 286, 1377-1381.
97. Murphy A., Westwood J. A., Teng M. W., Moeller M., Darcy P. K. and Kershaw M. H. (2005): Gene modification strategies to induce tumor immunity. Immunity, 22, 403-414.
98. Myrick C., DiGuisto R., DeWolfe J., Bowen E., Kappler J., Marrack P. and Wakeland E. K. (2002): Linkage analysis of variations in CD4:CD8 T cell subsets between C57BL/6 and DBA/2. Genes Immun., 3, 144-150.
99. Naka T., Nishimoto N. and Kishimoto T. (2002): The paradigm of IL-6: from basic science to medicine. Arthritis Res., 4 (suppl. 3), S233-242.
100. Nurieva R., Yang X. O., Martinez G., Zhang V., Panopoulos A.D., Ma L., Schluns K., Tian Q., Watowich S. S., Jetten A. M. and Dong C. (2007): Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature, 448, 480-483.
101. Ochsenbein A. F., Sierro S., Odermatt B., Pericin M., Karrer U., Hermans J., Hemmi S., Hengartner H. and Zinkernagel R. M. (2001): Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature, 411, 1058-1064.
102. Okada M., Kitahara M., Kishimoto S., Matsuda T., Hirano T. and Kishimoto T. (1988): IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J. Immunol., 141, 1543-1549.
103. Opferman J. T., Letai A., Beard C., Sorcinelli M. D., Ong C. C. and Korsmeyer S. J. (2003): Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature, 426, 671-676.
104. Pamer E. and Cresswell P. (1998): Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol., 16, 323-358.
105. Park J. H., Yu Q., Erman B., Appelbaum J. S., Montoya-Durango D., Grimes H. L. and Singer A. (2004): Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines; a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity, 21, 289-302.
106. Parrish-Novak J., Dillon S. R., Nelson A., Hammond A., Sprecher C., Gross J. A., Johnston J., Madden K., Xu W., West J., Schrader S., Burkhead S., Hepel M., Brandt C., Kuijper J. L., Kramer J., Conklin D., Presnell S. R., Berry J., Shiota F., Bort S., Hambly K., Mudri S., Clegg C., Moore M., Grant F. J., Lofton-Day C., Gilbert T., Rayond F., Ching A., Yao L., Smith D., Webster P., Whitmore T., Maurer M., Kaushansky K., Hally R. D. and Foster D. (2000): Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature, 408, 57-63.
107. Peacock C. D., Kim S. K. and Welsh R. M. (2003): Attrition of virus-specific memory CD8+ T cells during reconstitution of lymphopenic environments. J. Immunol., 171, 655-663.
108. Peng S. L., Robert M. E., Hayday A. C. and Craft J. (1996): A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice. J. Exp. Med., 184, 1149-1154.
109. Permar S. R., Moss W. J., Ryon J. J., Douek D. C., Monze M. and Griffin D. E. (2003): Increased thymic output during acute measles virus infection. J. Virol., 77, 7872-7879.
110. Peschon J. J., Morrissey P. J., Grabstein K. H., Ramsdell F. J., Maraskovsky E., Gliniak B. C., Park L. S., Ziegler S. F., Williams D. E., Ware C. B., Mayer J. D. and Davison B. L. (1994): Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med., 180, 1955-1960.
111. Phan G. Q., Yang J. C., Sherry R. M., Hwu P., Topalian S. L., Schwartzentruber D. J., Restifor N. P., Haworth L. R., Seipp C. A., Freezer L. J., Morton K. E., Mavroukakis S. A., Duray P. H., Steinberg S. M., Allison J. P., Davis T. A. and Rosenberger S. A. (2003): Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA, 100, 8372-8377.
112. Ramanathan S., Gagnon J., Leblanc C., Rottapel R. and Ilangumaran S. (2006): Suppressor of cytokine signaling 1 stringently regulates distinct functions of IL-7 and IL-15 in vivo during T lymphocyte development and homeostasis. J. Immunol., 176, 4029-4041.
113. Ramanathan S. and Poussier P. (2001): BB rat lyp mutation and Type 1 diabetes. Immunol. Rev., 184, 161-171.
114. Ramsey C., Rubinstein M. P., Kim D. M., Cho J. H., Sprent J. and Surh C. D. (2008): The lymphopenic environment of CD132 (common gamma-chain)-deficient hosts elicits rapid homeostatic proliferation of naive T cells via IL-15. J. Immunol., 180, 5320-5326.
115. Randriamampita C., Boulla G., Revy P., Lemaitre F. and Trautmann A. (2003): T cell adhesion lowers the threshold for antigen detection. Eur. J. Immunol., 33, 1215-1223.
116. Rathmell J. C., Farkash E. A., Gao W. and Thompson C. B. (2001): IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol., 167, 6869-6876.
117. Renauld J. C., Vink A. and Van Snick J. (1989): Accessory signals in murine cytolytic T cell responses. Dual requirement for IL-1 and IL-6. J. Immunol., 143, 1894-1898.
118. Renkvist N., Castelli C., Robbins P. F. and Parmiani G. (2001): A listing of human tumor antigens recognized by T cells. Cancer Immunol. Immunother., 50, 3-15.
119. Revy P., Sospedra M., Barbour B. and Trautmann A. (2001): Functional antigen-independent synapses formed between T cells and dendritic cells. Nat. Immunol., 2, 925-931.
120. Ridge J. P., Di Rosa F. and Matzinger P. (1998): A conditioned dendritic cell can be a temporal bridge between a CD4+ T- helper and a T-killer cell. Nature, 393, 474-478.
121. Robbins P. F., Dudley M. E., Wunderlich J., El-Gamil M., Li Y. F., Zhou J., Huang J., Powell D. J. Jr. and Rosenberg S. A. (2004): Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J. Immunol., 173, 7125-7130.
122. Rocha B., Dautigny N. and Pereira P. (1989): Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo. Eur. J. Immunol., 19, 905-911.
123. Rochman I., Paul W. E. and Ben-Sasson S. Z. (2005): IL-6 increases primed cell expansion and survival. J. Immunol., 174, 4761-4767.
124. Rosenberg S. A., Restifo N. P., Yang J. C., Morgan R. A. and Dudley M. E. (2008): Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer, 8, 299-308.
125. Rosenberg S. A., Sherry R. M., Morton K. E., Sharfman W. J., Yang J. C., Topalian S. L., Royal R. E., Kammula U., Restifo N. P., Hughes M. S., Schwartzentruber D., Berman D. M., Schwarz S. L., Ngo L. T., Mavroukakis S. A., White D. E. and Steinberg S. M. (2005): Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J. Immunol., 175, 6169-6176.
126. Rosenberg S. A., Yang J. C., White D. E. and Steinberg S. M. (1998): Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann. Surg., 228, 307-319.
127. Ruckert R., Brandt K., Bulanova E., Mirghomizadeh F., Paus R. and Bulfone-Paus S. (2003): Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur. J. Immunol., 33, 3493-3503.
128. Sadelain M., Riviere I. and Brentjens R. (2003): Targeting tumours with genetically enhanced T lymphocytes. Nat. Rev. Cancer, 3, 35-45.
129. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A. C. and Horak I. (1993): Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell, 75, 253-261.
130. Sallusto F., Langenkamp A., Geginat J. and Lanzavecchia A. (2000): Functional subsets of memory T cells identified by CCR7 expression. Curr. Top Microbiol. Immunol., 251, 167-171.
131. Samoilova E. B., Horton J. L., Hilliard B., Liu T. S. and Chen Y. (1998): IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol., 161, 6480-6486.
132. Schluns K. S., Kieper W. C., Jameson S. C. and Lefrancois L. (2000): Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol., 1, 426-432.
133. Schuler G. and Steinman R. M. (1997): Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med., 186, 1183-1187.
134. Schuler-Thurner B., Schultz E. S., Berger T. G., Wienlich G., Ebner S., Woerl P., Bender A., Feuerstein B., Fritsch P. O., Romani N. and Schuler G. (2002): Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J. Exp. Med., 195, 1279-1288.
135. Selin L. K., Lin M. Y., Kraemer K. A., Pardoll D. M., Schneck J. P., Varga S. M., Santolucito P. A., Pinto A. K. and Welsh R. M. (1999): Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity, 11, 733-742.
136. Selin L. K., Vergilis K., Welsh R. M. and Nahill S. R. (1996): Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J. Exp. Med., 183, 2489-2499.
137. Sepulveda H., Cerwenka A., Morgan T. and Dutton R. W. (1999): CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. J. Immunol., 163, 1133-1142.
138. Shankaran V., Ikeda H., Bruce A. T., White J. M., Swanson P. E., Old L. J. and Schreiber R. D. (2001): IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature, 410, 1107-1111.
139. Skak K., Kragh M., Hausman D., Smyth M. J. and Sivakumar P. V. (2008): Interleukin 21: combination strategies for cancer therapy. Nat. Rev. Drug Discov., 7, 231-240.
140. Smith D. K., Dudani R., Pedras-Vasconcelos J. A., Chapdelaine Y., van Faassen H. and Sad S. (2002): Cross-reactive antigen is required to prevent erosion of established T cell memory and tumor immunity: a heterologous bacterial model of attrition. J. Immunol., 169, 1197-1206.
141. Staveley-O'Carroll K., Sotomayor E., Montgomery J., Borrello I., Hwang L., Fein S., Pardoll D. and Levitsky H. (1998): Induction of antigen-specific T cell anergy: An early event in the course of tumor progression. Proc. Natl. Acad. Sci. USA, 95, 1178-1183.
142. Sun J. C. and Bevan M. J. (2003): Defective CD8 T cell memory following acute infection without CD4 T cell help. Science, 300, 339-342.
143. Suzuki H., Kundig T. M., Furlonger C., Wakeham A., Timms E., Matsuyama T., Schmits R., Simard J. J., Ohashi P. S., Griesser H. et al. (1995): Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science, 268, 1472-1476.
144. Tagaya Y., Bamford R. N., DeFilippis A. P. and Waldmann T. A. (1996): IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity, 4, 329-336.
145. Tajima M., Wakita D., Noguchi D., Chamoto K., Yue Z., Fugo K., Ishigame H., Iwakura Y., Kitamura H. and Nishimura T. (2008): IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J. Exp. Med., 205, 1019-1027
146. Takeda K., Kaisho T., Yoshida N., Takeda J., Kishimoto T. and Akira S. (1998): Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol., 161, 4652-4660.
147. Tan J. T., Dudl E., LeRoy E., Murray R., Sprent J., Weinberg K. I. and Surh C. D. (2001): IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA, 98, 8732-8737.
148. Tan J. T., Ernst B., Kieper W. C., LeRoy E., Sprent J. and Surh C. D. (2002): Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8(+) cells but are not required for memory phenotype CD4(+) cells. J. Exp. Med., 195, 1523-1532.
149. Tanchot C., Lemonnier F. A., Perarnau B., Freitas A. A. and Rocha B. (1997): Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science, 276, 2057-2062.
150. Tanchot C. and Rocha B. (1997): Peripheral selection of T cell repertoires: the role of continuous thymus output. J. Exp. Med., 186, 1099-1106.
151. Tanchot C., Rosado M. M., Agenes F., Freitas A. A. and Rocha B. (1997): Lymphocyte homeostasis. Semin. Immunol., 9, 331-337.
152. Teague T. K., Marrack P., Kappler J. W. and Vella A. T. (1997): IL-6 rescues resting mouse T cells from apoptosis. J. Immunol., 158, 5791-5796.
153. Tough D. F., Borrow P. and Sprent J. (1996): Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science, 272, 1947-1950.
154. Tough D. F. and Sprent J. (1996): Viruses and T cell turnover: evidence for bystander proliferation. Immunol. Rev., 150, 129-142.
155. Tough D. F., Sun S. and Sprent J. (1997): T cell stimulation in vivo by lipopolysaccharide (LPS). J. Exp. Med., 185, 2089-2094.
156. van den Broek M. E., Kagi D., Ossendorp F., Toes R., Vamvakas S., Lutz W. K., Melief C. J., Zinkernagel R. M. and Hengartner H. (1996): Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med., 184, 1781-1790.
157. Van Parijs L. and Abbas A. K. (1998): Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science, 280, 243-248.
158. van Stipdonk M. J., Lemmens E. E. and Schoenberger S. P. (2001): Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol., 2, 423-429.
159. Veiga-Fernandes H., Walter U., Bourgeois C., McLean A. and Rocha B. (2000): Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat. Immunol., 1, 47-53.
160. Vella A. T., Dow S., Potter T. A., Kappler J. and Marrack P. (1998): Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 95, 3810-3815.
161. von Freeden-Jeffry U., Vieira P., Lucian L. A., McNeil T., Burdach S. E. and Murray R. (1995): Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med., 181, 1519-1526.
162. von Herrath M. G., Fujinami R. S. and Whitton J. L. (2003): Microorganisms and autoimmunity: making the barren field fertile? Nat. Rev. Microbiol., 1, 151-157.
163. Walter U. and Santamaria P. (2005): CD8+ T cells in autoimmunity. Curr. Opin. Immunol., 17, 624-631.
164. Weissenbach M., Clahsen T., Weber C., Spitzer D., Wirth D., Vestweber D., Heinrich P. C. and Schaper F. (2004): Interleukin-6 is a direct mediator of T cell migration. Eur. J. Immunol., 34, 2895-2906.
165. Weninger W., Crowley M. A., Manjunath N. and von Andrian U. H. (2001): Migratory properties of naive, effector, and memory CD8(+) T cells. J. Exp. Med., 194, 953-566.
166. Whitmire J. K., Tan J. T. and Whitton J. L. (2005): Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection. J. Exp. Med., 201, 1053-1059.
167. Wong P. and Pamer E. G. (2001): Cutting edge: antigen-independent CD8 T cell proliferation. J. Immunol., 166, 5864-5868.
168. Wu T. S., Lee J. M., Lai Y. G., Hsu J. C., Tsai C. Y., Lee Y. H. and Liao N. S. (2002): Reduced expression of Bcl-2 in CD8+ T cells deficient in the IL-15 receptor alpha-chain. J. Immunol., 168, 705-712.
169. Yasukawa H., Sasaki A. and Yoshimura A. (2000): Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol., 18, 143-164.
170. Zeng R., Spolski R., Casas E., Zhu W., Levy D. E. and Leonard W. J. (2007): The molecular basis of IL-21-mediated proliferation. Blood, 109, 4135-4142.
171. Zeng R., Spolski R., Finkelstein S. E., Oh S., Kovanen P. E., Hinrichs C. S., Pise-Masison C. A., Radonovich M. F., Brady J. N., Restifo N. P., Berzofsky J. A. and Leonard W. J. (2005): Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J. Exp. Med., 201, 139-148.
172. Zhang X., Sun S., Hwang I., Tough D. F. and Sprent J. (1998): Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity, 8, 591-599.
173. Zou W. (2005): Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer, 5, 263-274.